Vulvodynia Intervention: the Effect of Multimodal Treatment for Provoked Vulvodynia
Launched by KARLSTAD UNIVERSITY · May 12, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new treatment approach for women suffering from provoked vulvodynia, which is a condition that causes chronic pain in the vulvar area. The goal is to see if a combination of different treatments—called multimodal treatment—can help reduce pain and improve overall sexual and emotional well-being. Over four months, participants will engage in 11 sessions that include both online meetings and some in-person visits. These sessions will involve different healthcare professionals and may even include partners in two of the sessions.
To be eligible for this trial, women must be between 18 and 40 years old and diagnosed with provoked vulvodynia. They should not have severe psychological issues, be pregnant, or have given birth in the past year. Participants can expect to undergo a gynecological examination and psychological assessment at the start, followed by the treatment sessions. They will also fill out questionnaires about their pain and relationships and may participate in an interview about their experiences. This trial is currently recruiting participants, and it aims to gather valuable feedback from patients and healthcare providers on how well the treatment works and how it can be improved.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Biological sex: Female 18-40 years old Provoked vulvodynia
- Exclusion Criteria:
- • Severe psychological issues that should be prioritized before vulvodynia treatment (e.g., substance abuse, psychosis)
- • Ongoing pregnancy
- • Childbirth within the last year
- • Post-traumatic stress disorder (PTSD) related to sexual trauma
- • Insufficient mastery of the Swedish language
- • No experience of vaginal sex, as vaginismus might be suspected, which requires different treatment
About Karlstad University
Karlstad University is a prominent academic institution located in Sweden, recognized for its commitment to innovative research and development across various disciplines. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at advancing healthcare solutions and improving patient outcomes. Karlstad University leverages its expertise in social sciences, health, and technology to contribute to evidence-based practices, fostering partnerships with healthcare providers and industry stakeholders. Through its clinical research initiatives, the university aims to translate scientific knowledge into real-world applications, ultimately enhancing the quality of life for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Karlstad, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported